Reimagining preventive medicine through genomics, AI, and early risk detection

About Author: Sudhakar Kancharla, Founder and President, Yoda Diagnostics is a serial entrepreneur operating at the intersection of healthcare, diagnostics, genomics, and high-end IT services. He has established three world-class molecular diagnostic laboratories in the United States and founded six advanced IT companies focused on high-end computing solutions. His return to India during the COVID-19 pandemic became a turning point, inspiring the creation of the Yoda Healthcare Group. He has also founded the Avasthita Foundation to advance societal upliftment.

The healthcare system in India has always been centered on treating the illness once the symptoms are visible. Whether in ancient or contemporary healthcare systems, the emphasis has always been on cure rather than prevention. In many Indian families, the healthcare system is still considered a priority only when it becomes an absolute necessity. But this is also changing. The preventive healthcare system is slowly becoming a revolutionary way of thinking that emphasizes early awareness and intervention.

The preventive healthcare system changes the basic question from “What went wrong?” to “What could go wrong, and how can we prevent it?” Rather than waiting for symptoms to become visible, this system identifies potential health risks early. Early detection does not mean that the health problem is inevitable. It simply means that there is an opportunity to monitor health closely, make lifestyle changes, and take medical advice before things go out of hand.

The Role of Genomics: Understanding Risk at Its Root

Genomics, the science of understanding our DNA, is at the forefront of this new shift. Our DNA is a biological blueprint inherited from our ancestors that determines how our bodies function, how we process nutrients, how we react to stress, and how likely we are to develop certain diseases.

Genomic screening can help detect inherited risks for diseases such as cardiovascular disease, diabetes, autoimmune diseases, neurological disorders, and certain cancers. Often, it is only after multiple occurrences that families will research serious diseases. At this point, precious time may have been wasted. Genomic screening provides early warning of potential risks, enabling individuals to take preventive measures well before the disease develops.

It is essential to understand that genetic risk does not mean inevitability. Rather, it provides clarity and foresight. For instance, if an individual inherits a genetic risk for heart disease, they can immediately make lifestyle choices that promote heart health, regularly track key health indicators, and seek guidance from medical professionals.

AI in Healthcare: Turning Data into Action

Although Genomics provides valuable insights, genetic information is vast and complex. This is where Artificial Intelligence (AI) revolutionizes the process. AI processes large amounts of genetic information, combined with medical history, lifestyle trends, and nutritional information, to provide actionable advice.

Instead of providing complex scientific reports, AI interprets genetic information into simple, easy-to-understand advice. It helps detect early risks by recognizing patterns that may not be visible in regular analysis.

AI has advanced to the point where it can analyze your past medical records and seamlessly connect them with your current health data to create a continuous, integrated health ecosystem. By tracking trends over time, it can monitor your progress, identify patterns, and provide personalized insights, suggestions, and lifestyle or treatment adjustments to help you maintain optimal health and stable parameters.

Personalized Preventive Care and Family Health

When preventive approaches are informed by genomic knowledge and fueled by AI, the healthcare system becomes highly targeted. Rather than following generic health tips, people can focus on areas where they are most susceptible, such as inflammation, metabolism, the immune system, or cardiovascular health.

Genomics helps enhance preventive healthcare at the family level as well. Because family members share genetic predispositions, knowledge of genetic risks in one person can help inform preventive action in another. If a genetic predisposition to heart disease or diabetes is discovered, siblings or offspring can be screened and take preventive steps early in life.

Pharmacogenomics and nutrigenomics together advance personalized preventive healthcare by using genetic insights to guide both medication and nutrition decisions. Pharmacogenomics helps determine how an individual will respond to specific drugs, enabling safer prescriptions, accurate dosing, and fewer side effects. Nutrigenomics, on the other hand, examines how genes influence nutrient metabolism and dietary responses, enabling personalized nutrition plans that reduce disease risk.

When combined with AI-driven data analysis, these fields create a proactive healthcare model predicting responses to treatments and diet in advance, minimizing trial and error, and promoting long-term, personalized wellness rather than reactive care. AI provides personalized diet recommendations based on genetic metabolism, analyses nutritional intake of carbohydrates, proteins, fats, vitamins, and minerals, and helps detect potential deficiencies.

Outlook

The future of healthcare will be more about prediction and prevention than just treatment. As genomic testing and AI tools increasingly become part of the mainstream healthcare system, personalized preventive strategies could become the norm.

Looking ahead, people will have comprehensive health plans personalized to their DNA, including risk assessments for chronic diseases, personalized dietary recommendations, lifestyle management, medication compatibility analysis and ongoing health monitoring. This proactive approach could lead to lower healthcare expenses, a lower incidence of chronic diseases, and a better overall quality of life.